Sandu Pharmaceuticals share news, announcements and annual reports
BSE: 524703Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹35.31.
30 Oct: open ₹35.56, high ₹36.40, low ₹35.01
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹35 Cr3,677th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 19.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.78%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,591
Sandu Pharmaceuticals share news and announcements
659 announcements, routine notices left out, newest first. Page 11 of 14.
Oct 2017
14 Oct · Management
10 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....7 Oct · Updates
Sep 2017
30 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....29 Sep · Meeting
14 Sep · Results
Aug 2017
Jul 2017
17 Jul · Statement Of Investor Complain For The Quarter Ended 30Th June 2017
8 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....
May 2017
18 May · Intimation About The Board Meeting To Be Held On Tuesday ,30Th May 2017
Apr 2017
18 Apr · Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Half Year Ended 31St March 2017
7 Apr · Compliance Certificate For The Half Year Ended 31St March 2017
7 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
Mar 2017
Feb 2017
22 Feb · Postponement of Board Meeting
15 Feb · Board Meeting on Feb 25, 2017
14 Feb · Familiarization Programme for Independent Directors
Jan 2017
19 Jan · Board Meeting on Jan 28, 2017
11 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
7 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Nov 2016
14 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 14, 2016, inter alia, has discussed the following business: - ....
Oct 2016
12 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
8 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
Sep 2016
17 Sep · Board Meeting on Sept 30, 2016
Aug 2016
13 Aug · Board meeting
Meeting of the Board of Directors of the Company duly convened on August 13, 2016, inter alia, discussed the following business - 1. ....13 Aug · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2016 to September 30, 2016 (both days ....
Jul 2016
13 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
9 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....
Jun 2016